well, explains the sell down.
will be interested to see the structure of the raise. Hopefully some cornerstone investors to drive marketing hard post FDA approval. Rather have a war chest of cash earlier on to be honest
also, expanding product pipeline was a focus from the AGM preso. Maybe they want to buy another drug.
not concerned either way, company is run by legit people this isnt a lifestyle company
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.005(1.45%) |
Mkt cap ! $39.74M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 36.3¢ | 33.0¢ | $140.4K | 407.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1271 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 9449 | 3 |
View Market Depth
| Last trade - 12.53pm 31/07/2025 (20 minute delay) ? |
| LTP (ASX) Chart |